Ramanan A, Feldman B. Clinical outcomes in juvenile dermatomyositis. Curr Opin Rheumatol. 2002;14:658-62.
Vinen CS, Patel S, Bruckner FE. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy. Rheumatology. 2000; 39:333-4.
Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Méndez EP, Kinder JM, et al. TNF(-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum. 2000;43:2368-77.
Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP, et al. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002;47:505-11.
Muckamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr. 2001;138:763-6.
